Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Françoise
Françoise Baleux, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110015368 | CD4-RECEPTOR-DERIVED PEPTIDES AND METHOD FOR THE PREPARATION THEREOF - The present invention relates to an activated peptide derived from the CD4 receptor, which is capable of coupling by covalent bonding to an organic molecule and thus makes it possible to generate multiple potentially antiviral derivatives. The present invention also relates to a conjugated molecule comprising the CD4-receptor-derived peptide and an organic molecule, preferably the GPR1 peptide or a polyanion. Such a conjugated molecule can in particular be used in antiviral treatments, in particular the treatment of AIDS. The invention also relates to the methods for preparing the activated peptide derived from the CD4 receptor and the conjugated molecule. | 01-20-2011 |
| 20110105412 | CONJUGATED MOLECULES COMPRISING A PEPTIDE DERIVED FROM THE CD4 RECEPTOR COUPLED TO A POLYANION FOR THE TREATMENT OF AIDS - This invention relates to a conjugated molecule comprising a peptide derived from the CD4 receptor coupled to an organic molecule by means of a linker as well as a process for its preparation. Such a conjugated molecule can be used in antiviral treatment, namely in the treatment of AIDS. | 05-05-2011 |
Françoise Baleux, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20080242601 | Selective Inhibition of Nf-Kappab Activiation by Peptides Designed to Disrupt Nemo Oligomerization - The present invention relates to polypeptides that inhibit the NF-&kgr; B signaling pathway and polynucleotides encoding the same. The present invention further provides methods for the modulation of and/or treatment of inflammatory responses, oncogenesis, viral infection; the regulation of cell proliferation and apoptosis; and regulation of B or T lymphocytes in antigenic stimulation, by administering the polypeptides of the present invention to a subject in need thereof. Finally, the present invention provides a method of identifying polypeptides that modulate oligomerization of NEMO. | 10-02-2008 |
| 20080293620 | Immunogenic Glycopeptides for Diagnosing Pathogenic Microorganisms Infections - A method for diagnosing an infection in a patient likely to be infected with a pathogenic microorganism, comprising the detection of CD4+ T lymphocytes recognizing at least one glycopeptide derived from said pathogenic microorganism, essentially consisting of a glycosylated T epitope, comprising from 14 to 25 amino acids, among which at least one neutral amino acid is bonded to a disaccharide or to a trisaccharide, and at least 15% of said amino acids are prolines, one of the prolines being located in position −1 to −4, relative to the position of said neutral amino acid. | 11-27-2008 |
| 20100240040 | METHOD FOR SCREENING FOR SELECTIVE MODULATOR OF THE NF-KB PATHWAY ACTIVATION - The invention relates to methods for screening for selective modulator of NF-κB pathway activation. The invention concerns methods for primary screening molecules that potentially modulate (activate or inhibit) the NF-κB pathway activation by identifying and selecting molecules modulate the interaction of NEMO with other proteins. The invention also concerns methods for secondary screening for modulator (activator or inhibitor) of the NF-κB pathway activation. | 09-23-2010 |
| 20110015368 | CD4-RECEPTOR-DERIVED PEPTIDES AND METHOD FOR THE PREPARATION THEREOF - The present invention relates to an activated peptide derived from the CD4 receptor, which is capable of coupling by covalent bonding to an organic molecule and thus makes it possible to generate multiple potentially antiviral derivatives. The present invention also relates to a conjugated molecule comprising the CD4-receptor-derived peptide and an organic molecule, preferably the GPR1 peptide or a polyanion. Such a conjugated molecule can in particular be used in antiviral treatments, in particular the treatment of AIDS. The invention also relates to the methods for preparing the activated peptide derived from the CD4 receptor and the conjugated molecule. | 01-20-2011 |
| 20110034383 | CXCL12 GAMMA A CHEMOKINE AND USES THEREOF - Fragments of CXCL12 Gamma A chemokine having improved chemotaxis activity in vivo defined by an unprecedented capacity to associate and immobilise on extracellular glycans. | 02-10-2011 |
| 20110105412 | CONJUGATED MOLECULES COMPRISING A PEPTIDE DERIVED FROM THE CD4 RECEPTOR COUPLED TO A POLYANION FOR THE TREATMENT OF AIDS - This invention relates to a conjugated molecule comprising a peptide derived from the CD4 receptor coupled to an organic molecule by means of a linker as well as a process for its preparation. Such a conjugated molecule can be used in antiviral treatment, namely in the treatment of AIDS. | 05-05-2011 |
Françoise Belaubre, Villeneuve Tolosane FR
| Patent application number | Description | Published |
|---|---|---|
| 20120093749 | USE OF DELTA-TOCOPHERYL-CARBOHYDRATE AS A DEPIGMENTING AGENT - The present invention relates to a cosmetic or pharmaceutical composition for cutaneous application, whose goal is the depigmentation of the skin. | 04-19-2012 |
Françoise Bernerd, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20090239254 | Functional pigmented skin equivalent - An in vitro skin equivalent includes at least one epidermis equivalent and at least one dermis equivalent, and further includes melanocytes constitutively producing melanin and fibroblasts. | 09-24-2009 |
| 20100055694 | Molecular signature representative of dysfunctions in epidermal homeostasis - The present invention concerns a method for evaluating the epidermal homeostasis of the skin of a subject, comprising differential analysis of the expression of a gene, preferably of two genes, selected from the group of genes consisting of KRT6B, KRT16, ESRRA, CBX3, MAP3K5, TRIO, PIK3CD, TCRB, PRRG2, ICP22BP, GPX3, GBA, BPGM, NID1, SMT3H2, LGALS2, DOC1, PRKCG, S100A8, S100A9, S100A2, S100A7, K15, SPRR1B and GSN in response to a physical or chemical challenge of the stratum corneum. It also concerns various methods for diagnosing the state of the epidermis of an individual and methods for detecting and screening products or procedures which can improve epidermal homeostasis. The invention also pertains to kits and arrays which can be used in these various methods and processes. | 03-04-2010 |
Françoise Bernerd, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100055694 | Molecular signature representative of dysfunctions in epidermal homeostasis - The present invention concerns a method for evaluating the epidermal homeostasis of the skin of a subject, comprising differential analysis of the expression of a gene, preferably of two genes, selected from the group of genes consisting of KRT6B, KRT16, ESRRA, CBX3, MAP3K5, TRIO, PIK3CD, TCRB, PRRG2, ICP22BP, GPX3, GBA, BPGM, NID1, SMT3H2, LGALS2, DOC1, PRKCG, S100A8, S100A9, S100A2, S100A7, K15, SPRR1B and GSN in response to a physical or chemical challenge of the stratum corneum. It also concerns various methods for diagnosing the state of the epidermis of an individual and methods for detecting and screening products or procedures which can improve epidermal homeostasis. The invention also pertains to kits and arrays which can be used in these various methods and processes. | 03-04-2010 |
Françoise Brochard-Wyart, Saint-Cloud FR
| Patent application number | Description | Published |
|---|---|---|
| 20110206751 | STIMULATABLE ASYMMETRICAL POLYMERSOME - The invention relates to a polymer vesicle with an asymmetrical unilamellar membrane, said membrane being constituted by two distinct layers, a layer (A) and a layer (B), said layers comprising respective amphiphilic block copolymers with layer (A) comprising, in contrast to said layer (B), an effective quantity of amphiphilic block copolymer comprising at least one stimulatable hydrophobic polymer block, said block polymers provided by said copolymers being capable of adopting a new steric configuration in response to an exogenous stimulus, conditioning the rupture of said unilamellar membrane. The invention also provides a method of producing said vesicle, a method of encapsulating an active ingredient in said vesicles, and a method of controlled release of the active ingredient. | 08-25-2011 |
Françoise Budar, Les Molieres FR
| Patent application number | Description | Published |
|---|---|---|
| 20100299779 | METHOD OF PRODUCING DOUBLE LOW RESTORER LINES OF BRASSICA NAPUS HAVING A GOOD AGRONOMIC VALUE - The invention relates to a method of producing a double low restorer line of | 11-25-2010 |
Françoise Budar, Les Molieres FR
| Patent application number | Description | Published |
|---|---|---|
| 20100299779 | METHOD OF PRODUCING DOUBLE LOW RESTORER LINES OF BRASSICA NAPUS HAVING A GOOD AGRONOMIC VALUE - The invention relates to a method of producing a double low restorer line of | 11-25-2010 |
Françoise Cailler, Montpellier FR
| Patent application number | Description | Published |
|---|---|---|
| 20110177062 | METHODS FOR TREATING BREAST CANCER - The present disclosure is directed to methods of treating and preventing breast cancer or recurrence of breast cancer with compositions comprising anti-progastrin antibodies. | 07-21-2011 |
Françoise Corvaisier, Antony FR
| Patent application number | Description | Published |
|---|---|---|
| 20110040802 | SHARED BUSINESS INTELLIGENCE ELEMENTS - Some aspects relate to reception of a selection of a business intelligence report element in a first business intelligence report of a first file format, creation of a serialized description of the business intelligence report element in a second file format based on a business intelligence report element data model, reception of an instruction to add the business intelligence report element to a second business intelligence report of a third file format, and addition of the business intelligence report element to the second business intelligence report in the third file format based on the serialized description of the business intelligence report element. | 02-17-2011 |
Françoise Corvaisier, Antony FR
| Patent application number | Description | Published |
|---|---|---|
| 20110040802 | SHARED BUSINESS INTELLIGENCE ELEMENTS - Some aspects relate to reception of a selection of a business intelligence report element in a first business intelligence report of a first file format, creation of a serialized description of the business intelligence report element in a second file format based on a business intelligence report element data model, reception of an instruction to add the business intelligence report element to a second business intelligence report of a third file format, and addition of the business intelligence report element to the second business intelligence report in the third file format based on the serialized description of the business intelligence report element. | 02-17-2011 |
Françoise De Laveleye-Defais, Brussels BE
| Patent application number | Description | Published |
|---|---|---|
| 20100105681 | 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS - The present invention concerns 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals. | 04-29-2010 |
Françoise De Laveleye-Defais, Brussels BE
| Patent application number | Description | Published |
|---|---|---|
| 20100105681 | 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS - The present invention concerns 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals. | 04-29-2010 |
Françoise Dignat-George, Marseille FR
| Patent application number | Description | Published |
|---|---|---|
| 20110286963 | HUMAN SOLUBLE CD146, PREPARATION AND USES THEREOF - The present invention relates to compositions and methods for modulating angiogenesis in vivo, ex vivo or in vitro. More particularly, the invention relates to a soluble CD 146 protein usable in the context of human therapy, as well as to corresponding antibodies. Particular forms of CD 146, herein described, may be used to mobilize, in vivo or ex vivo, both mature and immature endothelial cells, as well as to increase their influence on angiogenesis. The invention also relates to compositions comprising such compounds, particularly pharmaceutical or diagnostic compositions, including kits and the like, as well as methods of therapy or diagnosis using said compounds, compositions and cells. | 11-24-2011 |
Françoise Gavini, Mons En Baroeul FR
| Patent application number | Description | Published |
|---|---|---|
| 20100310513 | BIFIDOBACTERIAL SPECIES - New bacterium GC61 belonging to the genus | 12-09-2010 |
Françoise Gavini, Mons En Baroeul FR
| Patent application number | Description | Published |
|---|---|---|
| 20080274085 | Probiotic Bifidobacterial Species - A probiotic composition comprising a | 11-06-2008 |
| 20100310513 | BIFIDOBACTERIAL SPECIES - New bacterium GC61 belonging to the genus | 12-09-2010 |
Françoise Giannetti Born Rouzaud, Toulouse FR
| Patent application number | Description | Published |
|---|---|---|
| 20120102794 | TIMELESS IDENTIFICATION PASSPORT - A funerary article for the identification and perpetuation of the memory of a deceased individual in a timeless manner, made of unalterable material, includes: a marked element ( | 05-03-2012 |
Françoise Hervagault, Orsay FR
| Patent application number | Description | Published |
|---|---|---|
| 20120135857 | NOVEL ORGANOMETALLIC COMPOUNDS CONTAINING A METAL BELONGING TO THE SECOND COLUMN OF THE PERIODIC TABLE, AND METHOD FOR PREPARING SAME - The present invention relates to a novel organometallic compound based on a divalent metal belonging to the 2 | 05-31-2012 |
Françoise Khuong-Huu, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20120040930 | TETRACYCLIC TERPENE SERIES COMPOUNDS, METHODS FOR PREPARING SAME, USES THEREOF AS MEDICINES AND PHARMACEUTICAL COMPOUNDS CONTAINING SAME - The invention concerns a triterpene alkaloid of general formula (I). The invention also concerns a method for making same and use thereof as medicine. | 02-16-2012 |
Françoise Lavialle, Antony FR
| Patent application number | Description | Published |
|---|---|---|
| 20100178702 | EXTRACELLULAR VESICLES FROM NON-PATHOGENIC AMOEBAE USEFUL AS VEHICLE FOR TRANSFERRING A MOLECULE OF INTEREST TO AN EUKARYOTIC CELL - The invention relates to membrane vesicles from non-pathogenic amoeba, in particular from the amoeba | 07-15-2010 |
Françoise Lavialle, Antony FR
| Patent application number | Description | Published |
|---|---|---|
| 20100178702 | EXTRACELLULAR VESICLES FROM NON-PATHOGENIC AMOEBAE USEFUL AS VEHICLE FOR TRANSFERRING A MOLECULE OF INTEREST TO AN EUKARYOTIC CELL - The invention relates to membrane vesicles from non-pathogenic amoeba, in particular from the amoeba | 07-15-2010 |
Françoise Megret, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20120009216 | EARLY DETECTION OF FLAVIVIRUSES USING THE NS1 GLYCOPROTEIN - The invention concerns a method for early detection of a flavivirus-induced infection, comprising the detection of the flavivirus non-structural glycoprotein NS1 in a biological sample during the clinical phase of the infection, by an immunological method using at least two identical or different antibodies, the first antibody consisting of polyclonal or monoclonal antibodies pre-selected for their high affinity for said NS1 protein hexameric in shape. | 01-12-2012 |
Françoise Pataut, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20090053150 | Aerosol device containing at least one amps polymer and at least one fixing polymer - The invention concerns a composition packaged in an aerosol container, containing (c) at least a propellant and (b) a hair-styling composition including at least (i) one non polyurethane anionic or nonionic fixing polymer and (ii) at least one polymer comprising at least one ethylenically unsaturated monomer having a sulphonic group, in free form, or partly or totally neutralized. | 02-26-2009 |
| 20100202997 | Cosmetic Composition for the Hair with a Waxy Effect, in Aerosol Form - The disclosure relates to a cosmetic composition for the hair, packaged in an aerosol device, comprising polyols in high concentration together with anionic fixing polymers. It further relates to a cosmetic method for the hair comprising the application of this composition to the hair, and to its use for imparting a waxy effect to the hair. | 08-12-2010 |
Françoise Pataut, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100202997 | Cosmetic Composition for the Hair with a Waxy Effect, in Aerosol Form - The disclosure relates to a cosmetic composition for the hair, packaged in an aerosol device, comprising polyols in high concentration together with anionic fixing polymers. It further relates to a cosmetic method for the hair comprising the application of this composition to the hair, and to its use for imparting a waxy effect to the hair. | 08-12-2010 |
Françoise Pellicier, Loury FR
| Patent application number | Description | Published |
|---|---|---|
| 20100233298 | COSMETIC USE OF PHYTOSPHINGOSINE AS SLIMMING AGENT AND COSMETIC COMPOSITIONS COMPRISING PHYTOSPHINGOSINE - The invention relates to novel cosmetic uses of phytosphingosine or of one of its cosmetically acceptable salts, particularly its hydrochloride, as a slimming agent and/or as an active agent which stimulates the synthesis of leptin by adipocytes, for preparing a cosmetic composition intended for reducing subcutaneous excess fat. | 09-16-2010 |
| 20100316745 | Use of a cereal extract as a slimming active agent in a slimming cosmetic composition - A cereal extract is cosmetically used and obtained by at least one polar solvent. This cereal extract is used as a slimming agent in a slimming cosmetic composition. The cosmetic use makes it possible to achieve an effective slimming cosmetic care with a natural, nontoxic slimming agent. | 12-16-2010 |
| 20110091588 | ORCHID VANDA COERULEA AS A COSMETIC ACTIVE AGENT - An extract of the orchid | 04-21-2011 |
Françoise Pellicier, Loury FR
| Patent application number | Description | Published |
|---|---|---|
| 20100233298 | COSMETIC USE OF PHYTOSPHINGOSINE AS SLIMMING AGENT AND COSMETIC COMPOSITIONS COMPRISING PHYTOSPHINGOSINE - The invention relates to novel cosmetic uses of phytosphingosine or of one of its cosmetically acceptable salts, particularly its hydrochloride, as a slimming agent and/or as an active agent which stimulates the synthesis of leptin by adipocytes, for preparing a cosmetic composition intended for reducing subcutaneous excess fat. | 09-16-2010 |
| 20100316745 | Use of a cereal extract as a slimming active agent in a slimming cosmetic composition - A cereal extract is cosmetically used and obtained by at least one polar solvent. This cereal extract is used as a slimming agent in a slimming cosmetic composition. The cosmetic use makes it possible to achieve an effective slimming cosmetic care with a natural, nontoxic slimming agent. | 12-16-2010 |
| 20110091588 | ORCHID VANDA COERULEA AS A COSMETIC ACTIVE AGENT - An extract of the orchid | 04-21-2011 |
Françoise Sailhan, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100278184 | Method of Processing Event Notifications and Event Subscriptions - A method of processing event subscriptions in a telecommunications or data network comprising a plurality of nodes organized in clusters, in multiple layers. Each cluster has a cluster leader. The method comprises maintaining by each node a routing table comprising a list of nodes in its cluster and a repository of event subscriptions; forwarding an ascending subscription by a node to all nodes within its cluster and to its cluster's leader; forwarding a descending subscription to all nodes of all layers that the node is a leader and adding a received event subscription to the event subscriptions repository and associating said subscription with a node, which forwarded it. | 11-04-2010 |
Françoise Sailhan, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100020721 | Arrangement and Method Relating to Routing of IP Traffic in Mobile Wireless Newtorks - The present invention relates to a proactive optimized link state protocol and a node with routing means supporting such a protocol implementing multipoint relaying for distribution of control messages, e.g. comprising hello messages, which are extended and comprise neighbour information, link status information and resource related information, and second control messages, e.g. TC messages comprising information relating to MPR selectors which are extended to also hold information of a shared information repository ( | 01-28-2010 |
| 20100278184 | Method of Processing Event Notifications and Event Subscriptions - A method of processing event subscriptions in a telecommunications or data network comprising a plurality of nodes organized in clusters, in multiple layers. Each cluster has a cluster leader. The method comprises maintaining by each node a routing table comprising a list of nodes in its cluster and a repository of event subscriptions; forwarding an ascending subscription by a node to all nodes within its cluster and to its cluster's leader; forwarding a descending subscription to all nodes of all layers that the node is a leader and adding a received event subscription to the event subscriptions repository and associating said subscription with a node, which forwarded it. | 11-04-2010 |
| 20110188378 | Arrangement and Method Relating to Network Management - The present invention relates to a network management system for management of a traffic network comprising a wired as well as a wireless network backbone. The wireless network backbone comprises relay nodes comprising wireless routers, some acting as gateways to the wired backbone network and some as relay bridge routers for access network access. The management system comprises a logical multilevel hierarchical network overlying the traffic network. It is adapted to use the infrastructure of the traffic network by using the relay nodes as management stations. It comprises grouping means adapted to perform a grouping process by arranging network nodes, comprising the relay nodes, in groups, each with selected a cluster head, on different hierarchical levels. Grouping control means are provided to control the grouping and allocation of cluster heads based on a number of grouping constraints given by one or more criteria to be fulfilled at each hierarchical level. Calculating means are adapted to calculate the criteria based on given metrics and modeling and verification means are provided for modeling the constraints and verifying fulfillment of said constraints at each hierarchical level. | 08-04-2011 |
| 20110191460 | System and a Method Relating to Network Management - The present invention relates to a node supporting networking and communication with other nodes by means of a layered communication protocol and group communication with other nodes controlled via a grouping protocol adapted to interact with said communication protocol. The node comprises a policy engine which is arranged separately from, but in communication with said grouping protocol. The policy engine is adapted to establish current and/or changing node, group and network related information and to use one or more grouping policies to automatically and dynamically control grouping related actions and adapt the grouping. The invention also relates to a system comprising a number of such nodes and a method of controlling grouping. | 08-04-2011 |
Françoise Schmutz, Givry FR
| Patent application number | Description | Published |
|---|---|---|
| 20100078277 | Valve Assembly for Damper between a Lower Chamber and a Compensation Chamber in the Damper - A valve assembly is provided. The valve assembly includes a valve sliding in a valve holder and a base. The valve holder is held by the base by a resilient holding mechanism, the valve holder is mobile with respect to the base between a compression position and an expansion position. The valve holder includes a seat and a body extending beneath the seat and extending into the base. The holding mechanism is fixed on the one hand to the body of the valve holder and includes at least one portion extending beneath the lower face of the base, the portion resting against the lower face when the valve holder is in the expansion position. A damper is also provided. | 04-01-2010 |